# High‐Frequency Ultrasound Evaluation of Cutaneous Surgical Wound Healing: An Outpatient Experience

**Authors:** Anna Russo, Vittorio Patanè, Lucrezia Bucciero, Maria Cristina Pezzella, Mario Brunese, Francesco Stanzione, Mario Faenza, Alfonso Reginelli

PMC · DOI: 10.1111/wrr.70136 · Wound Repair and Regeneration · 2026-02-27

## TL;DR

High-frequency ultrasound can track skin wound healing phases non-invasively, offering a reliable way to monitor recovery and detect abnormal scarring.

## Contribution

Validates HFUS as a quantitative, reproducible tool for monitoring postoperative wound healing phases in real time.

## Key findings

- Dermal thickness decreased and echogenicity increased over time, reflecting collagen maturation.
- Vascularity peaked during the granulation phase and declined with healing, matching angiogenesis patterns.
- HFUS showed excellent reproducibility (ICC = 0.91; κ = 0.82) for morphologic and vascular measurements.

## Abstract

High‐frequency ultrasound (HFUS) allows non‐invasive visualization of skin microarchitecture, offering quantitative assessment of dermal composition and vascularity, but its systematic use to track temporal changes in postoperative wound healing is still limited. This study aimed to describe and validate HFUS morphologic and vascular features corresponding to the biological phases of cutaneous surgical wound healing. A total of 730 patients who underwent surgical excision of skin lesions were evaluated at different postoperative intervals using high‐ and ultra‐high‐frequency ultrasound (48–70 MHz). Dermal thickness, echogenicity and vascularity were analysed with B‐mode and colour Doppler imaging through quantitative and semi‐quantitative methods and reproducibility was assessed using intraclass correlation coefficients (ICC) and Cohen's κ statistics. Cross‐sectional analysis demonstrated a progressive structural and vascular evolution consistent with canonical healing phases: dermal thickness decreased from 2.45 ± 0.38 mm at T0 to 1.58 ± 0.21 mm at T4, while echogenicity increased from 0.5 [0–1] to 2.5 [2, 3], reflecting collagen compaction and maturation. Vascularity peaked at T2 (2.2 ± 0.5) and declined to 0.8 ± 0.3 by T4, paralleling the regression of angiogenesis. Measurement reproducibility was excellent (ICC = 0.91; κ = 0.82). HFUS morphologic patterns closely mirrored the biological sequence from inflammatory oedema through granulation and fibroplasia to collagen remodelling, providing real‐time in vivo correlates of tissue repair. These findings support HFUS as a reliable, quantitative and reproducible tool for monitoring postoperative wound healing and as a potential imaging biomarker framework for early detection of abnormal scar evolution.

## Full-text entities

- **Genes:** TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** tumour (MESH:D009369), Hematoma (MESH:D006406), melanoma (MESH:D008545), fibrosis (MESH:D005355), Seroma (MESH:D049291), Complications (MESH:D008107), melanocytic lesions (MESH:D009508), inflammation (MESH:D007249), abscess (MESH:D000038), wounds (MESH:D014947), inflammatory dermatoses (MESH:D012871), wound dehiscence (MESH:D013529), HFUS (MESH:D006316), cutaneous lesions (MESH:D009059), fibroplasia (MESH:D012178), scar (MESH:D002921), keloid (MESH:D007627), infection (MESH:D007239), inflammatory oedema (MESH:C536897), radiodermatitis (MESH:D011855), basal cell carcinoma (MESH:D002280), erythema (MESH:D004890), chronic (MESH:D002908), tissue damage (MESH:D017695), Hypertrophic (MESH:D002312)
- **Chemicals:** prostaglandins (MESH:D011453), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949109/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949109/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949109/full.md

---
Source: https://tomesphere.com/paper/PMC12949109